Literature DB >> 27432013

Identification of two novel mutations in the COMP gene in six families with pseudoachondroplasia.

Wei-Jia Yu1, Zeng Zhang2, Jin-Wei He1, Wen-Zhen Fu1, Chun Wang1, Zhen-Lin Zhang1.   

Abstract

Pseudoachondroplasia (PSACH; MIM no. 177170) is an autosomal dominant osteochondrodysplasia characterized by short‑limb short stature, brachydactyly and early‑onset osteoarthropathy. Typically, at approximately two years of age, the rate of growth falls below the standard growth curve, causing a moderately severe form of disproportionate short‑limb short stature. The current study described the clinical and radiographic observations of six Chinese patients with PSACH, and identified two de novo novel missense mutations [p.Asp326Asn (c.976G>A) and c.1585A>G (p.Thr529Ala)] in cartilage oligomeric matrix protein (COMP) in the patients. The current study expanded the mutation spectrum of the COMP gene, and contributes to the understanding of phenotype/genotype of COMP‑associated diseases.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27432013     DOI: 10.3892/mmr.2016.5486

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  3 in total

1.  Clinical, Biochemical, Radiological, Genetic and Therapeutic Analysis of Patients with COMP Gene Variants.

Authors:  Hanting Liang; Yanfang Hou; Qianqian Pang; Yan Jiang; Ou Wang; Mei Li; Xiaoping Xing; Huijuan Zhu; Weibo Xia
Journal:  Calcif Tissue Int       Date:  2021-10-28       Impact factor: 4.333

2.  The molecular mechanism study of COMP involved in the articular cartilage damage of Kashin-Beck disease.

Authors:  Mei Ma; Xiao Liang; Xi Wang; Lu Zhang; Shiqiang Cheng; Xiong Guo; Feng Zhang; Yan Wen
Journal:  Bone Joint Res       Date:  2020-09-20       Impact factor: 5.853

3.  Orthopaedic manifestations of pseudoachondroplasia.

Authors:  D S Weiner; J Guirguis; M Makowski; S Testa; L Shauver; D Morgan
Journal:  J Child Orthop       Date:  2019-08-01       Impact factor: 1.548

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.